Search Results

ENCHANT Will Evaluate ChEVAR Technique With Medtronic's Endurant II/IIs Stent Graft System

January 24, 2018—Medtronic announced the launch of the ENCHANT trial, which will evaluate the chimney endovascular aneurysm repair (ChEVAR) parallel graft technique using the company's Endurant II/IIs stent graft system.

Medtronic Endurant II/IIs Receives CE Mark for ChEVAR Indication

December 6, 2016—Medtronic announced that it has received European CE Mark approval for the Endurant II/IIs stent graft system to treat abdominal aortic aneurysm (AAA) patients using a chimney endovascular aortic repair (ChEVAR) procedure.

European Postmarket Registry Begins for Gore's TAG Conformable Thoracic Stent Graft With Active Control System

November 2, 2017—Gore & Associates recently announced the first enrollment in its postmarket European SURPASS registry for its TAG conformable thoracic stent graft with Active Control system.

Study Shows Acceptable Long-Term Patency of SFA Stents

November 16, 2012—At the VEITH Symposium in New York City, Giovanni Torsello, MD, presented data showing that more than half of patients treated for claudication or critical limb ischemia (CLI) with stenting of the superficial femoral artery (SFA) retained primary patency at 5 years.

Gore's TAG Conformable Thoracic Stent Graft With Active Control System Approved in Europe

July 13, 2017—Gore & Associates announced the first patient implant of its TAG conformable thoracic stent graft with Active Control System, which received European CE Mark approval in June for thoracic endovascular aortic repair (TEVAR).

Medtronic's Valiant Studies Complete Enrollment

October 7, 2009—Medtronic, Inc. (Minneapolis, MN) announced the completion of enrollment in two clinical trials studying the use of the company's Valiant thoracic stent graft system for treating descending thoracic aortic aneurysms (TAAs) and descending thoracic aortic dissections, respectively.